Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

ClinicalTrials.gov ID: NCT06638307

Public ClinicalTrials.gov record NCT06638307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, First-in-Human Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Participants With Advanced Breast Cancer

Study identification

NCT ID
NCT06638307
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Stemline Therapeutics, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • Elacestrant Drug
  • MEN2312 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2024
Primary completion
May 31, 2026
Completion
Sep 30, 2026
Last update posted
May 11, 2026

2024 – 2026

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Highlands Oncology Group Springdale Arkansas 72703 Recruiting
City of Hope Duarte California 31010 Recruiting
UC San Diego Moores Cancer Center La Jolla California 92093-0698 Recruiting
Stanfod Cancer Center Palo Alto California 94304 Recruiting
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 Recruiting
UCLA Hematology Oncology - Parkside Santa Monica California 90404 Recruiting
Yale Comprehensive Cancer Center New Haven Connecticut 06511 Recruiting
Advent Health Orlando Altamonte Springs Florida 32701 Recruiting
Sarah Cannon Research Institute at Florida Cancer Specialists Orlando Florida 32827 Recruiting
Florida Cancer Specialists & Research Institute (FCS) - Sarasota Sarasota Florida 34232 Recruiting
Moffitt Cancer Center Tampa Florida 33612 Recruiting
Winship Cancer Institute, Emory University Atlanta Georgia 30322 Recruiting
University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center) Chicago Illinois 60612 Recruiting
University of Iowa Health Care Iowa City Iowa 52242 Recruiting
Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 Recruiting
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 Recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
START Midwest - Oncology Grand Rapids Michigan 49546 Recruiting
Mayo Clinic Rochester Minnesota 55905 Recruiting
Astera Cancer Care East Brunswick New Jersey 08816 Recruiting
Perlmutter Cancer Center - Sunset Park Brooklyn New York 11220 Recruiting
Perlmutter Cancer Center at NYU Langone Hospital - Long Island Mineola New York 11501 Recruiting
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 Recruiting
Providence Cancer Institute Franz Clinic Portland Oregon 97213 Recruiting
SCRI Oncology Partners Group Nashville Tennessee 37203 Recruiting
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 Recruiting
START San Antonio, LLC San Antonio Texas 78229 Recruiting
University of Texas Health Science Center San Antonio San Antonio Texas 78229 Recruiting
START Mountain West Valley City Utah 84119 Recruiting
NEXT Virginia Fairfax Virginia 22031 Recruiting
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53792 Recruiting
Froedtert Hospital & the Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06638307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06638307 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →